Verastem Debt to Equity Ratio 2011-2018 | VSTM

Current and historical debt to equity ratio values for Verastem (VSTM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Verastem debt/equity for the three months ending June 30, 2018 was 0.19.
Verastem Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-06-30 $0.02B $0.13B 0.19
2018-03-31 $0.02B $0.04B 0.39
2017-12-31 $0.02B $0.06B 0.26
2017-09-30 $0.00B $0.04B 0.06
2017-06-30 $0.00B $0.05B 0.05
2017-03-31 $0.00B $0.06B 0.04
2016-12-31 $0.00B $0.07B 0.00
2016-09-30 $0.00B $0.08B 0.00
2016-06-30 $0.00B $0.09B 0.00
2016-03-31 $0.00B $0.10B 0.00
2015-12-31 $0.00B $0.10B 0.00
2015-09-30 $0.00B $0.11B 0.00
2015-06-30 $0.00B $0.13B 0.00
2015-03-31 $0.00B $0.13B 0.00
2014-12-31 $0.00B $0.09B 0.00
2014-09-30 $0.00B $0.09B 0.00
2014-06-30 $0.00B $0.10B 0.00
2014-03-31 $0.00B $0.11B 0.00
2013-12-31 $0.00B $0.12B 0.00
2013-09-30 $0.00B $0.13B 0.00
2013-06-30 $0.00B $0.08B 0.00
2013-03-31 $0.00B $0.08B 0.00
2012-12-31 $0.00B $0.09B 0.00
2012-09-30 $0.00B $0.10B 0.00
2012-06-30 $0.00B $0.10B 0.00
2012-03-31 $0.00B $0.11B 0.00
2011-12-31 $0.00B $-0.01B 0.00
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $-0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.431B $0.000B
Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate for combination therapy with immuno-oncology agents and other anti-cancer compounds. The company's defactinib is in Phase 1b study for the treatment of pancreatic cancer, as well as in Phase 1/2 clinical trial for the treatment of ovarian cancer, non-small cell lung cancer, mesothelioma, and pancreatic cancer. It also engages in developing duvelisib, an investigational oral therapy that targets the PI3K signaling pathway, as well as attacks malignant B-cells and T-cells and disrupt the tumor microenvironment to help thwart their growth and proliferation for patients with lymphatic cancers through the dual inhibition of PI3K delta and gamma.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.215B 15.06
Gilead Sciences (GILD) United States $96.150B 10.67
Biogen (BIIB) United States $66.506B 14.10
Celgene (CELG) United States $58.344B 11.65
Illumina (ILMN) United States $47.253B 59.20
Vertex Pharmaceuticals (VRTX) United States $45.720B 104.01
Regeneron Pharmaceuticals (REGN) United States $42.706B 24.01
Alexion Pharmaceuticals (ALXN) United States $28.205B 21.20
BioMarin Pharmaceutical (BMRN) United States $18.437B 0.00
Incyte (INCY) United States $13.698B 460.29
Seattle Genetics (SGEN) United States $11.706B 0.00
Sarepta Therapeutics (SRPT) United States $9.222B 0.00
QIAGEN (QGEN) Netherlands $8.091B 26.45
Alnylam Pharmaceuticals (ALNY) United States $7.911B 0.00
Exact Sciences (EXAS) United States $7.791B 0.00
Bio-Techne Corp (TECH) United States $6.919B 46.28
BeiGene (BGNE) Cayman Islands $6.673B 0.00
Bluebird Bio (BLUE) United States $6.615B 0.00
Alkermes (ALKS) Ireland $6.337B 0.00
Amarin (AMRN) Ireland $5.879B 0.00
Galapagos (GLPG) Belgium $5.385B 0.00
Exelixis (EXEL) United States $4.924B 16.04
Immunomedics (IMMU) United States $4.241B 0.00
Ligand Pharmaceuticals (LGND) United States $4.159B 36.83
GUARDANT HEALTH (GH) United States $3.351B 0.00
Myriad Genetics (MYGN) United States $3.332B 35.39
Array BioPharma (ARRY) United States $3.292B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.219B 0.00
Horizon Pharma Public (HZNP) Ireland $3.181B 18.01
Emergent Biosolutions (EBS) United States $3.086B 24.58
MorphoSys AG Unsponsored ADR (MOR) Germany $3.078B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.940B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.841B 0.00
Ascendis Pharma (ASND) Denmark $2.772B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.695B 0.00
Halozyme Therapeutics (HALO) United States $2.538B 33.83
Repligen (RGEN) United States $2.475B 83.10
Genomic Health (GHDX) United States $2.437B 135.92
China Biologic Products (CBPO) China $2.394B 16.46
Acceleron Pharma (XLRN) United States $2.378B 0.00
Amicus Therapeutics (FOLD) United States $2.324B 0.00
MyoKardia (MYOK) United States $2.232B 0.00
REGENXBIO (RGNX) United States $2.016B 31.67
Medicines (MDCO) United States $2.010B 0.00
Arena Pharmaceuticals (ARNA) United States $2.000B 0.00
Global Blood Therapeutics (GBT) United States $1.986B 0.00
Akcea Therapeutics (AKCA) United States $1.955B 0.00
AnaptysBio (ANAB) United States $1.953B 0.00
Cambrex (CBM) United States $1.888B 15.14
Spark Therapeutics (ONCE) United States $1.874B 0.00
Reata Pharmaceuticals (RETA) United States $1.818B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.795B 0.00
Allakos (ALLK) United States $1.788B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.756B 0.00
Puma Biotechnology (PBYI) United States $1.657B 0.00
Atara Biotherapeutics (ATRA) United States $1.622B 0.00
Aimmune Therapeutics (AIMT) United States $1.620B 0.00
Clovis Oncology (CLVS) United States $1.577B 0.00
Innoviva (INVA) United States $1.570B 10.08
G1 THERAPEUTICS (GTHX) United States $1.567B 0.00
Denali Therapeutics (DNLI) United States $1.561B 0.00
Sangamo Therapeutics (SGMO) United States $1.443B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.435B 0.00
WAVE Life Sciences (WVE) Singapore $1.432B 0.00
Myovant Sciences (MYOV) United Kingdom $1.389B 0.00
Rubius Therapeutics (RUBY) United States $1.357B 0.00
Mirati Therapeutics (MRTX) United States $1.355B 0.00
Editas Medicine (EDIT) United States $1.352B 0.00
Insmed (INSM) United States $1.312B 0.00
IMMURON LTD (IMRN) Australia $1.287B 0.00
Solid Biosciences (SLDB) United States $1.258B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.202B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.187B 2267.00
Momenta Pharmaceuticals (MNTA) United States $1.154B 0.00
NeoGenomics (NEO) United States $1.140B 199.43
Cellectis (CLLS) France $1.122B 0.00
DBV Technologies (DBVT) France $1.087B 0.00
UniQure (QURE) Netherlands $1.047B 0.00
Lion Biotechnologies (IOVA) United States $1.044B 0.00
Audentes Therapeutics (BOLD) United States $1.035B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.033B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.027B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.026B 0.00
Retrophin (RTRX) United States $1.025B 0.00
Intra-Cellular Therapies (ITCI) United States $1.025B 0.00
Intellia Therapeutics (NTLA) United States $1.006B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.961B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.957B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.916B 0.00
Athenex (ATNX) United States $0.903B 0.00
Acorda Therapeutics (ACOR) United States $0.901B 18.78
Revance Therapeutics (RVNC) United States $0.896B 0.00
Aptinyx (APTX) United States $0.883B 0.00
Viking Therapeutics (VKTX) United States $0.876B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.875B 0.00
Coherus BioSciences (CHRS) United States $0.862B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.808B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.790B 0.00
Cara Therapeutics (CARA) United States $0.784B 0.00
Apellis Pharmaceuticals (APLS) United States $0.779B 0.00
InflaRx (IFRX) Germany $0.775B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.767B 0.00
Heska (HSKA) United States $0.750B 64.57
Novavax (NVAX) United States $0.746B 0.00
CytomX Therapeutics (CTMX) United States $0.740B 0.00
Fate Therapeutics (FATE) United States $0.736B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.727B 0.00
Dynavax Technologies (DVAX) United States $0.712B 0.00
Epizyme (EPZM) United States $0.696B 0.00
AVROBIO (AVRO) United States $0.687B 0.00
Mesoblast (MESO) Australia $0.664B 0.00
ANI Pharmaceuticals (ANIP) United States $0.662B 13.10
AC Immune SA (ACIU) Switzerland $0.634B 0.00
ObsEva SA (OBSV) Switzerland $0.613B 0.00
Anika Therapeutics (ANIK) United States $0.595B 25.04
Kura Oncology (KURA) United States $0.591B 0.00
UROGEN PHARMA (URGN) Israel $0.581B 0.00
MiMedx (MDXG) United States $0.575B 24.67
Arcus Biosciences (RCUS) United States $0.551B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.547B 0.00
RA PHARMCTL INC (RARX) United States $0.531B 0.00
Aduro Biotech (ADRO) United States $0.514B 0.00
Principia Biopharma (PRNB) United States $0.507B 0.00
Vericel (VCEL) United States $0.507B 0.00
Five Prime Therapeutics (FPRX) United States $0.507B 0.00
Inovio Pharmaceuticals (INO) United States $0.505B 0.00
ARVINAS INC (ARVN) United States $0.497B 0.00
UNITY Biotechnology (UBX) $0.496B 0.00
Prothena (PRTA) Ireland $0.489B 0.00
Scholar Rock Holding (SRRK) United States $0.487B 0.00
Kezar Life Sciences (KZR) United States $0.480B 0.00
Stemline Therapeutics (STML) United States $0.479B 0.00
Senesco Technologies (ELOX) United States $0.471B 0.00
Abeona Therapeutics (ABEO) United States $0.466B 0.00
MediciNova (MNOV) United States $0.451B 0.00
GRITSTONE ONCLG (GRTS) United States $0.447B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
Kindred Biosciences (KIN) United States $0.442B 0.00
Zealand Pharma (ZEAL) Denmark $0.428B 0.00
Cytokineticsorporated (CYTK) United States $0.425B 0.00
Liquidia Technologies (LQDA) United States $0.424B 0.00
Zymeworks (ZYME) Canada $0.423B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.421B 0.00
Sorrento Therapeutics (SRNE) United States $0.416B 71.20
Sinovac Biotech (SVA) China $0.411B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.383B 0.00
Replimune (REPL) United States $0.382B 0.00
Proteostasis Therapeutics (PTI) United States $0.380B 0.00
MeiraGTx Holdings (MGTX) United States $0.375B 0.00
PDL BioPharma (PDLI) United States $0.372B 5.22
UROVANT SCIENCS (UROV) United States $0.366B 0.00
KODIAK SCIENCES (KOD) United States $0.356B 0.00
Osiris Therapeutics (OSIR) United States $0.354B 0.00
Eidos Therapeutics (EIDX) United States $0.348B 0.00
Albireo Pharma (ALBO) United States $0.339B 0.00
ResTORbio (TORC) United States $0.339B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.339B 0.00
Selecta Biosciences (SELB) United States $0.339B 0.00
SUTRO BIOPHARMA (STRO) United States $0.332B 0.00
Magenta Therapeutics (MGTA) United States $0.325B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
Evelo Biosciences (EVLO) United States $0.317B 0.00
Kala Pharmaceuticals (KALA) United States $0.317B 0.00
Geron (GERN) United States $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Kadmon Holdings (KDMN) United States $0.310B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.307B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.301B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.298B 0.00
Adverum Biotechnologies (ADVM) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Unum Therapeutics (UMRX) United States $0.293B 0.00
Athersys (ATHX) United States $0.291B 0.00
Celcuity (CELC) United States $0.291B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.286B 0.00
Axovant Sciences (AXON) United Kingdom $0.286B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Celyad SA (CYAD) Belgium $0.257B 0.00
BioTime (BTX) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.253B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Syros Pharmaceuticals (SYRS) United States $0.245B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.238B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.237B 0.00
Synlogic (SYBX) United States $0.235B 0.00
Kamada (KMDA) Israel $0.232B 17.97
Idera Pharmaceuticals (IDRA) United States $0.231B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.229B 0.00
Krystal Biotech (KRYS) United States $0.227B 0.00
Agenus (AGEN) United States $0.227B 0.00
NantKwest (NK) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
BioDelivery Sciences (BDSI) United States $0.219B 0.00
Allena Pharmaceuticals (ALNA) United States $0.218B 0.00
Protagonist Therapeutics (PTGX) United States $0.212B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.207B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
Compugen (CGEN) Israel $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.192B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
Spring Bank Pharmaceuticals (SBPH) United States $0.184B 0.00
Constellation Pharmaceuticals (CNST) United States $0.183B 0.00
Cerecor (CERC) United States $0.182B 18.63
Eiger BioPharmaceuticals (EIGR) United States $0.171B 0.00
Clearside Biomedical (CLSD) United States $0.171B 0.00
Intec Pharma (NTEC) Israel $0.169B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.169B 0.00
Cohbar (CWBR) United States $0.165B 0.00
Enzo Biochem (ENZ) United States $0.162B 0.00
PSivida (EYPT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.154B 0.00
Signal Genetics (MGEN) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.145B 0.00
Pfenex (PFNX) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Cue Biopharma (CUE) United States $0.141B 0.00
Menlo Therapeutics (MNLO) United States $0.138B 0.00
VBI Vaccines (VBIV) United States $0.136B 0.00
Pluristem Therapeutics (PSTI) Israel $0.134B 0.00
Monster Digital (INNT) United States $0.134B 0.00
Mustang Bio (MBIO) United States $0.132B 0.00
XBiotech (XBIT) United States $0.130B 0.00
Eleven Biotherapeutics (SESN) United States $0.127B 0.00
Motif Bio Plc (MTFB) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.123B 0.00
Catalyst Biosciences (CBIO) United States $0.118B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
ITUS (ANIX) United States $0.117B 0.00
VTv Therapeutics (VTVT) United States $0.116B 0.00
XOMA (XOMA) United States $0.115B 12.13
Provention Bio (PRVB) United States $0.115B 0.00
Anavex Life Sciences (AVXL) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.110B 0.00
Axsome Therapeutics (AXSM) United States $0.108B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.103B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.102B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.100B 0.00
BioXcel Therapeutics (BTAI) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Aptevo Therapeutics (APVO) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.096B 0.00
VolitionRX (VNRX) Singapore $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.094B 0.00
ScPharmaceuticals (SCPH) United States $0.093B 0.00
Prima BioMed (IMMP) Australia $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
Cocrystal Pharma (COCP) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.55
Protalix BioTherapeutics (PLX) Israel $0.084B 0.00
Vaccinex (VCNX) United States $0.080B 0.00
NewLink Genetics (NLNK) United States $0.080B 0.00
Aptose Biosciences (APTO) Canada $0.079B 0.00
Sophiris Bio (SPHS) United States $0.077B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
BIONANO GENOMIC (BNGO) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.066B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
Trevena (TRVN) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.056B 0.00
Fortress Biotech (FBIO) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.050B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Celsion (CLSN) United States $0.047B 0.00
VIVUS (VVUS) United States $0.046B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
GTx (GTXI) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.037B 0.00
BioPharmX (BPMX) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Proteon Therapeutics (PRTO) United States $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
Moleculin Biotech (MBRX) United States $0.032B 0.00
CytRx (CYTR) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Histogenics (HSGX) United States $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.023B 46.33
Gemphire Therapeutics (GEMP) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Arsanis (ASNS) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
TrovaGene (TROV) United States $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.19
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.015B 0.00
Adial Pharmaceuticals (ADIL) United States $0.014B 0.00
Neuralstem (CUR) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Oragenics (OGEN) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00